0001209191-20-030494.txt : 20200519
0001209191-20-030494.hdr.sgml : 20200519
20200519163313
ACCESSION NUMBER: 0001209191-20-030494
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200515
FILED AS OF DATE: 20200519
DATE AS OF CHANGE: 20200519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tatsis Ourania
CENTRAL INDEX KEY: 0001789815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20894135
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001789815
Tatsis Ourania
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Regulatory Officer
Common Stock
2020-05-15
4
S
0
10
276.35
D
12848
D
Common Stock
2020-05-15
4
S
0
17
279.93
D
12831
D
Common Stock
2020-05-15
4
S
0
21
281.23
D
12810
D
Common Stock
2020-05-15
4
S
0
10
284.30
D
12800
D
Common Stock
2020-05-15
4
S
0
20
286.12
D
12780
D
Common Stock
2020-05-15
4
S
0
33
287.61
D
12747
D
Common Stock
2020-05-15
4
S
0
9
288.38
D
12738
D
Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $279.93 (range $279.68 to $280.53).
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $281.23 (range $280.73 to $281.62).
Open market sales reported on this line occurred at a weighted average price of $286.12 (range $285.79 to $286.44).
Open market sales reported on this line occurred at a weighted average price of $287.61 (range $287.04 to $287.99).
Open market sales reported on this line occurred at a weighted average price of $288.38 (range $288.20 to $288.47).
/s/ Sabrina Yohai, Attorney-in-Fact
2020-05-19